Bifogade filer
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från ProstaLund AB (publ) via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
2022-07-14 08:15:00
1 January-30 June
- Net sales reached SEK 3,5 (3,2) million
- Loss after taxes SEK -3,7 (-2,8) million
- Earnings per share were SEK -0,07 SEK (-0,07)
- Cash and equivalents were 4,4 (2,8) million
Significant events during period
- Agreement with Capio Specialistcenter. Order value SEK 2.4 million
- Agreement with Urogyn Sweden. Order value SEK 1,2 million
- The new platform, CoreTherm® Eagle, submitted for CE marking
- Distribution agreement signed for the Israeli market
1 April-30 June
- Net sales reached SEK 8,1 (8,5) million
- Loss after taxes SEK -5,8 (-3,9) million
- Earnings per share were SEK -0,11 SEK (-0,09)
Significant events after the end of the period
- The Board decides on a rights issue, which can provide the company with up to SEK 18 million before issue costs
Key figures | |||
(SEK MILLION) | jan-jun 2022 | jan-jun 2021 | jan-jun 2020 |
Net sales | 8,1 | 8,5 | 6,1 |
Gross margin, % | 76 | 87 | 66 |
Operating profit/loss | -5,8 | -3,9 | -4,7 |
Cash flow from operating activities | -9,5 | -3,2 | -4,2 |
Average number of employees | 7 | 7 | 5 |
“When I look at how the quarter developed with strong sales in the domestic market, submission for CE marking of the new platform and the great interest from the rest of Europe, I think it looks very exciting”
Johan Wennerholm
CEO, ProstaLund AB (publ)
*For complete report, please see attached PDF.